Robert J.A. Bell

2.2k total citations
23 papers, 1.2k citations indexed

About

Robert J.A. Bell is a scholar working on Molecular Biology, Physiology and Biotechnology. According to data from OpenAlex, Robert J.A. Bell has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Biotechnology. Recurrent topics in Robert J.A. Bell's work include Cancer Research and Treatments (5 papers), Salmonella and Campylobacter epidemiology (4 papers) and Telomeres, Telomerase, and Senescence (4 papers). Robert J.A. Bell is often cited by papers focused on Cancer Research and Treatments (5 papers), Salmonella and Campylobacter epidemiology (4 papers) and Telomeres, Telomerase, and Senescence (4 papers). Robert J.A. Bell collaborates with scholars based in United States, Australia and Portugal. Robert J.A. Bell's co-authors include J Costello, Jun S. Song, Andrew Mancini, H. Tomas Rube, Ana Xavier‐Magalhães, Bruno M. Costa, Kyle M. Walsh, Raman P. Nagarajan, Chibo Hong and Shaun D. Fouse and has published in prestigious journals such as Science, Nature Communications and PLoS ONE.

In The Last Decade

Robert J.A. Bell

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J.A. Bell United States 13 754 320 202 173 156 23 1.2k
Sirous Zeinali Iran 18 794 1.1× 63 0.2× 215 1.1× 151 0.9× 142 0.9× 112 1.3k
Lindsey Jones United States 18 632 0.8× 113 0.4× 344 1.7× 138 0.8× 332 2.1× 29 1.3k
Srdjan Novaković Slovenia 22 557 0.7× 66 0.2× 157 0.8× 87 0.5× 292 1.9× 114 1.3k
Ard Jonker Netherlands 19 453 0.6× 91 0.3× 285 1.4× 249 1.4× 133 0.9× 25 1.1k
Stefania Dell’Orso United States 18 1.8k 2.4× 220 0.7× 511 2.5× 93 0.5× 426 2.7× 37 2.4k
Lars Velten Germany 13 1.4k 1.9× 111 0.3× 237 1.2× 269 1.6× 229 1.5× 26 2.3k
S. Tamir Rashid United Kingdom 20 1.7k 2.3× 315 1.0× 175 0.9× 70 0.4× 198 1.3× 30 2.3k
Jamie M. Sperger United States 16 861 1.1× 171 0.5× 170 0.8× 32 0.2× 252 1.6× 37 1.3k
Bibhuti Mishra United States 20 1.0k 1.3× 128 0.4× 264 1.3× 79 0.5× 526 3.4× 38 1.6k
Travis W. Bainbridge United States 15 773 1.0× 258 0.8× 194 1.0× 40 0.2× 702 4.5× 23 1.6k

Countries citing papers authored by Robert J.A. Bell

Since Specialization
Citations

This map shows the geographic impact of Robert J.A. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J.A. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J.A. Bell more than expected).

Fields of papers citing papers by Robert J.A. Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J.A. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J.A. Bell. The network helps show where Robert J.A. Bell may publish in the future.

Co-authorship network of co-authors of Robert J.A. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J.A. Bell. A scholar is included among the top collaborators of Robert J.A. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J.A. Bell. Robert J.A. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shrestha, Ashish C., Russell Stafford, Robert J.A. Bell, et al.. (2023). Shiga Toxin‒Producing Escherichia coli Diagnoses from Health Practitioners, Queensland, Australia. Emerging infectious diseases. 30(1). 199–202.
2.
Osswald, Christian R., et al.. (2022). Initial Clinical Experience With ClearPoint SmartFrame Array–Aided Stereotactic Procedures. World Neurosurgery. 162. e120–e130. 10 indexed citations
3.
Kircher, Martin, Chenling Xiong, Beth Martin, et al.. (2019). Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution. Nature Communications. 10(1). 3583–3583. 131 indexed citations
4.
Mancini, Andrew, Ana Xavier‐Magalhães, Wendy S. Woods, et al.. (2018). Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner. Cancer Cell. 34(3). 513–528.e8. 96 indexed citations
5.
Ohba, Shigeo, Joydeep Mukherjee, Andrew Mancini, et al.. (2016). Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. Cancer Research. 76(22). 6680–6689. 50 indexed citations
6.
Chen, Justin, Christopher S. Hackett, Shile Zhang, et al.. (2015). The Genetics of Splicing in Neuroblastoma. Cancer Discovery. 5(4). 380–395. 13 indexed citations
7.
Bell, Robert J.A., H. Tomas Rube, Alex Kreig, et al.. (2015). The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science. 348(6238). 1036–1039. 398 indexed citations
8.
Bell, Robert J.A., H. Tomas Rube, Alex Kreig, et al.. (2015). Abstract B12: GABP selectively binds and activates the mutant TERT promoter across multiple cancer types. Cancer Research. 75(23_Supplement). B12–B12. 1 indexed citations
9.
Nagarajan, Raman P., Bo Zhang, Robert J.A. Bell, et al.. (2014). Recurrent epimutations activate gene body promoters in primary glioblastoma. Genome Research. 24(5). 761–774. 35 indexed citations
10.
Birnbaum, Ramon Y., Rupali P Patwardhan, Mee J. Kim, et al.. (2014). Systematic Dissection of Coding Exons at Single Nucleotide Resolution Supports an Additional Role in Cell-Specific Transcriptional Regulation. PLoS Genetics. 10(10). e1004592–e1004592. 31 indexed citations
11.
Clop, Alex, Anna Bertoni, Sarah L. Spain, et al.. (2013). An In-Depth Characterization of the Major Psoriasis Susceptibility Locus Identifies Candidate Susceptibility Alleles within an HLA-C Enhancer Element. PLoS ONE. 8(8). e71690–e71690. 32 indexed citations
12.
Song, Jun S., et al.. (2012). YY1 regulates melanocyte development and function by cooperating with MITF. eScholarship (California Digital Library). 37 indexed citations
13.
Nagarajan, Raman P., Shaun D. Fouse, Robert J.A. Bell, & J Costello. (2012). Methods for Cancer Epigenome Analysis. Advances in experimental medicine and biology. 754. 313–338. 12 indexed citations
14.
Zhang, Lu, Robert J.A. Bell, Michael A. Kiebish, et al.. (2011). A Mathematical Model for the Determination of Steady-State Cardiolipin Remodeling Mechanisms Using Lipidomic Data. PLoS ONE. 6(6). e21170–e21170. 12 indexed citations
15.
McCall, Bradley J, et al.. (2009). Outbreaks of Salmonella Typhimurium phage type 197 of multiple genotypes linked to an egg producer. Communicable Diseases Intelligence. 33. 419–425. 2 indexed citations
16.
McCall, Bradley J, et al.. (2009). Outbreaks of Salmonella Typhimurium phage type 197 of multiple genotypes linked to an egg producer. Communicable Diseases Intelligence. 33(4). 419–425. 17 indexed citations
17.
Black, Andrew P, et al.. (2005). Investigation of a multi-state outbreak of Salmonella Hvittingfoss using a web-based case reporting form. Communicable Diseases Intelligence. 29(4). 379–381. 10 indexed citations
18.
Quinn, Helen, et al.. (2005). Cluster of Salmonella Typhimurium phage type U307 associated with a restaurant. Communicable Diseases Intelligence. 29(1). 83–84. 1 indexed citations
19.
Ghosh, Sujoy & Robert J.A. Bell. (2003). Liposomes: Applications in Protein-Lipid Interaction Studies. Humana Press eBooks. 199. 49–60. 4 indexed citations
20.
McCall, Bradley J, et al.. (2003). An outbreak of Salmonella Typhimurium phage type 135a in a child care centre. Communicable Diseases Intelligence. 27(2). 257–259. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026